K991605 is an FDA 510(k) clearance for the CELL-DYN 3500 SYSTEM WITH IMMATURE RETICULOCYTE FRACTION (IRF), CELL-DYN 3700 SYSTEM WITH IMMATURE RETICULOCYTE FRACTION. This device is classified as a Counter, Differential Cell (Class II - Special Controls, product code GKZ).
Submitted by Abbott Laboratories (Santa Clara, US). The FDA issued a Cleared decision on July 9, 1999, 60 days after receiving the submission on May 10, 1999.
This device falls under the Hematology FDA review panel. Regulated under 21 CFR 864.5220.